サマリー

ジペプチジルペプチダーゼ-4インヒビターの世界市場規模は、2022年の12520百万米ドルから2029年には18380百万米ドルに成長すると予測され、2023年から2029年までのCAGRは5.6％と予測されています。
Dipeptidyl Peptidase-4 Inhibitorsの米国市場は、2023年から2029年までのCAGRで、2022年の100万米ドルから2029年には100万米ドルまで増加すると予測されています。
ジペプチジルペプチダーゼ-4阻害剤の中国市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
ジペプチジルペプチダーゼ-4阻害剤の欧州市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
世界の主要なジペプチジルペプチダーゼ-4阻害剤のプレーヤーは、Merck、Boehringer Ingelheim、AstraZeneca、武田薬品、Novartis、Jiangsu Hansoh Pharmaceutical、Qilu Pharmaceutical、Beijing Tide PharmaceuticalおよびCTTQなどをカバーしています。収益面では、2022年に世界の2大企業がほぼ％のシェアを占めています。
ジペプチジルペプチダーゼ-4阻害剤（DPP-4阻害剤）は、2型糖尿病の治療に用いられる薬の一種である。DPP-4は、膵臓のβ細胞からのインスリン分泌を刺激するホルモンであるインクレチンを分解する酵素です。DPP-4を阻害することにより、DPP-4阻害剤はインクレチン濃度を高め、2型糖尿病の患者さんのグルコースコントロールを改善します。DPP-4阻害剤の例としては、シタグリプチン、サキサグリプチン、リナグリプチン、アログリプチンなどがあります。これらの薬剤は、通常1日1回経口投与され、一般に良好な忍容性を示す。これらの薬剤は単独で、またはメトホルミンやインスリンなどの他の糖尿病治療薬と組み合わせて使用することができます。
LPI（エルピーアイ）の最新リサーチレポート「ジペプチジルペプチダーゼ-4阻害剤の業界予測」は、過去の売上高から2022年の世界のジペプチジルペプチダーゼ-4阻害剤の総売上を検討し、2023年から2029年の予測ジペプチジルペプチダーゼ-4阻害剤の売上を地域と市場分野ごとに包括的に分析しています。ジペプチジルペプチダーゼ-4阻害剤の売上を地域別、市場分野別、サブセクター別に分類し、世界のジペプチジルペプチダーゼ-4阻害剤産業の詳細な分析（百万米ドル単位）を提供します。
本インサイトレポートでは、世界のDipeptidyl Peptidase-4 Inhibitorsの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界のジペプチジルペプチダーゼ-4インヒビター市場におけるこれらの企業の独自のポジションをより理解するために、ジペプチジルペプチダーゼ-4インヒビターのポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントなどに焦点を当てて、世界の主要企業の戦略を分析しています。
本インサイトレポートでは、ジペプチジルペプチダーゼ-4阻害剤の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、本調査予測は、世界のジペプチジルペプチダーゼ-4阻害剤の現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、ジペプチジルペプチダーゼ-4インヒビター市場の製品タイプ、用途、主要メーカー、主要地域・国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
シタグリプチン
サキサグリプチン
ビルダグリプチン
リナグリプチン
アログリプチン
その他
アプリケーション別セグメント
病院
クリニック
その他
また、本レポートでは、市場を地域別に分類しています：
米州
ユーエスエー
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
連邦王国
イタリア
ロシア
中近東・アフリカ
エジプト
南ア
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選ばれています。
メルク
ベーリンガーインゲルハイム
アストラゼネカ
武田薬品工業
ノバルティス
江蘇漢創薬業
斉魯薬業
北京タイド製薬
CTTQ
江蘇徳源製薬
九江中天製薬
ヤバオ製薬
本レポートで扱う主な質問
世界のDipeptidyl Peptidase-4 Inhibitors市場の10年後の展望は？
世界および地域別に、ジペプチジルペプチダーゼ-4インヒビター市場の成長を促す要因は何か？
市場別、地域別で最も早く成長するのはどの技術か？
ジペプチジルペプチダーゼ-4阻害剤の市場機会は、最終市場規模によってどのように変化するか？
Dipeptidyl Peptidase-4 Inhibitorsのタイプ別、アプリケーション別の内訳は？
COVID-19とロシア・ウクライナ戦争の影響とは？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dipeptidyl Peptidase-4 Inhibitors Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Dipeptidyl Peptidase-4 Inhibitors by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Dipeptidyl Peptidase-4 Inhibitors by Country/Region, 2018, 2022 & 2029
2.2 Dipeptidyl Peptidase-4 Inhibitors Segment by Type
2.2.1 Sitagliptin
2.2.2 Saxagliptin
2.2.3 Vildagliptin
2.2.4 Linagliptin
2.2.5 Alogliptin
2.2.6 Other
2.3 Dipeptidyl Peptidase-4 Inhibitors Sales by Type
2.3.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2018-2023)
2.3.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue and Market Share by Type (2018-2023)
2.3.3 Global Dipeptidyl Peptidase-4 Inhibitors Sale Price by Type (2018-2023)
2.4 Dipeptidyl Peptidase-4 Inhibitors Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Dipeptidyl Peptidase-4 Inhibitors Sales by Application
2.5.1 Global Dipeptidyl Peptidase-4 Inhibitors Sale Market Share by Application (2018-2023)
2.5.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue and Market Share by Application (2018-2023)
2.5.3 Global Dipeptidyl Peptidase-4 Inhibitors Sale Price by Application (2018-2023)
3 Global Dipeptidyl Peptidase-4 Inhibitors by Company
3.1 Global Dipeptidyl Peptidase-4 Inhibitors Breakdown Data by Company
3.1.1 Global Dipeptidyl Peptidase-4 Inhibitors Annual Sales by Company (2018-2023)
3.1.2 Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Company (2018-2023)
3.2 Global Dipeptidyl Peptidase-4 Inhibitors Annual Revenue by Company (2018-2023)
3.2.1 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Company (2018-2023)
3.2.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Company (2018-2023)
3.3 Global Dipeptidyl Peptidase-4 Inhibitors Sale Price by Company
3.4 Key Manufacturers Dipeptidyl Peptidase-4 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dipeptidyl Peptidase-4 Inhibitors Product Location Distribution
3.4.2 Players Dipeptidyl Peptidase-4 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dipeptidyl Peptidase-4 Inhibitors by Geographic Region
4.1 World Historic Dipeptidyl Peptidase-4 Inhibitors Market Size by Geographic Region (2018-2023)
4.1.1 Global Dipeptidyl Peptidase-4 Inhibitors Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Dipeptidyl Peptidase-4 Inhibitors Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Dipeptidyl Peptidase-4 Inhibitors Market Size by Country/Region (2018-2023)
4.2.1 Global Dipeptidyl Peptidase-4 Inhibitors Annual Sales by Country/Region (2018-2023)
4.2.2 Global Dipeptidyl Peptidase-4 Inhibitors Annual Revenue by Country/Region (2018-2023)
4.3 Americas Dipeptidyl Peptidase-4 Inhibitors Sales Growth
4.4 APAC Dipeptidyl Peptidase-4 Inhibitors Sales Growth
4.5 Europe Dipeptidyl Peptidase-4 Inhibitors Sales Growth
4.6 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Growth
5 Americas
5.1 Americas Dipeptidyl Peptidase-4 Inhibitors Sales by Country
5.1.1 Americas Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2018-2023)
5.1.2 Americas Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2018-2023)
5.2 Americas Dipeptidyl Peptidase-4 Inhibitors Sales by Type
5.3 Americas Dipeptidyl Peptidase-4 Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dipeptidyl Peptidase-4 Inhibitors Sales by Region
6.1.1 APAC Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2018-2023)
6.1.2 APAC Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2018-2023)
6.2 APAC Dipeptidyl Peptidase-4 Inhibitors Sales by Type
6.3 APAC Dipeptidyl Peptidase-4 Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dipeptidyl Peptidase-4 Inhibitors by Country
7.1.1 Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2018-2023)
7.1.2 Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2018-2023)
7.2 Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Type
7.3 Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors by Country
8.1.1 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2018-2023)
8.1.2 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2018-2023)
8.2 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Type
8.3 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dipeptidyl Peptidase-4 Inhibitors
10.3 Manufacturing Process Analysis of Dipeptidyl Peptidase-4 Inhibitors
10.4 Industry Chain Structure of Dipeptidyl Peptidase-4 Inhibitors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dipeptidyl Peptidase-4 Inhibitors Distributors
11.3 Dipeptidyl Peptidase-4 Inhibitors Customer
12 World Forecast Review for Dipeptidyl Peptidase-4 Inhibitors by Geographic Region
12.1 Global Dipeptidyl Peptidase-4 Inhibitors Market Size Forecast by Region
12.1.1 Global Dipeptidyl Peptidase-4 Inhibitors Forecast by Region (2024-2029)
12.1.2 Global Dipeptidyl Peptidase-4 Inhibitors Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dipeptidyl Peptidase-4 Inhibitors Forecast by Type
12.7 Global Dipeptidyl Peptidase-4 Inhibitors Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.1.3 Merck Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.3.3 AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Takeda Pharmaceutical
13.4.1 Takeda Pharmaceutical Company Information
13.4.2 Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.4.3 Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Takeda Pharmaceutical Main Business Overview
13.4.5 Takeda Pharmaceutical Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.5.3 Novartis Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Jiangsu Hansoh Pharmaceutical
13.6.1 Jiangsu Hansoh Pharmaceutical Company Information
13.6.2 Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.6.3 Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
13.6.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.7 Qilu Pharmaceutical
13.7.1 Qilu Pharmaceutical Company Information
13.7.2 Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.7.3 Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Qilu Pharmaceutical Main Business Overview
13.7.5 Qilu Pharmaceutical Latest Developments
13.8 Beijing Tide Pharmaceutical
13.8.1 Beijing Tide Pharmaceutical Company Information
13.8.2 Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.8.3 Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Beijing Tide Pharmaceutical Main Business Overview
13.8.5 Beijing Tide Pharmaceutical Latest Developments
13.9 CTTQ
13.9.1 CTTQ Company Information
13.9.2 CTTQ Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.9.3 CTTQ Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 CTTQ Main Business Overview
13.9.5 CTTQ Latest Developments
13.10 Jiangsu Deyuan Pharmaceutical
13.10.1 Jiangsu Deyuan Pharmaceutical Company Information
13.10.2 Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.10.3 Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Deyuan Pharmaceutical Main Business Overview
13.10.5 Jiangsu Deyuan Pharmaceutical Latest Developments
13.11 Jiujiang Zhongtian Pharmaceutical
13.11.1 Jiujiang Zhongtian Pharmaceutical Company Information
13.11.2 Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.11.3 Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiujiang Zhongtian Pharmaceutical Main Business Overview
13.11.5 Jiujiang Zhongtian Pharmaceutical Latest Developments
13.12 Yabao Pharmaceutical
13.12.1 Yabao Pharmaceutical Company Information
13.12.2 Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
13.12.3 Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Yabao Pharmaceutical Main Business Overview
13.12.5 Yabao Pharmaceutical Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Dipeptidyl Peptidase-4 Inhibitors Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Dipeptidyl Peptidase-4 Inhibitors Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Sitagliptin
Table 4. Major Players of Saxagliptin
Table 5. Major Players of Vildagliptin
Table 6. Major Players of Linagliptin
Table 7. Major Players of Alogliptin
Table 8. Major Players of Other
Table 9. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Type (2018-2023) & (K Units)
Table 10. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2018-2023)
Table 11. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Type (2018-2023) & ($ million)
Table 12. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Type (2018-2023)
Table 13. Global Dipeptidyl Peptidase-4 Inhibitors Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Application (2018-2023) & (K Units)
Table 15. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2018-2023)
Table 16. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Application (2018-2023)
Table 17. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Application (2018-2023)
Table 18. Global Dipeptidyl Peptidase-4 Inhibitors Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Company (2018-2023) & (K Units)
Table 20. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Company (2018-2023)
Table 21. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Company (2018-2023)
Table 23. Global Dipeptidyl Peptidase-4 Inhibitors Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Dipeptidyl Peptidase-4 Inhibitors Producing Area Distribution and Sales Area
Table 25. Players Dipeptidyl Peptidase-4 Inhibitors Products Offered
Table 26. Dipeptidyl Peptidase-4 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share Geographic Region (2018-2023)
Table 31. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country/Region (2018-2023)
Table 35. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2018-2023) & (K Units)
Table 38. Americas Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2018-2023)
Table 39. Americas Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2018-2023)
Table 41. Americas Dipeptidyl Peptidase-4 Inhibitors Sales by Type (2018-2023) & (K Units)
Table 42. Americas Dipeptidyl Peptidase-4 Inhibitors Sales by Application (2018-2023) & (K Units)
Table 43. APAC Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2018-2023) & (K Units)
Table 44. APAC Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Region (2018-2023)
Table 45. APAC Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Region (2018-2023)
Table 47. APAC Dipeptidyl Peptidase-4 Inhibitors Sales by Type (2018-2023) & (K Units)
Table 48. APAC Dipeptidyl Peptidase-4 Inhibitors Sales by Application (2018-2023) & (K Units)
Table 49. Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2018-2023) & (K Units)
Table 50. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2018-2023)
Table 51. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2018-2023)
Table 53. Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Type (2018-2023) & (K Units)
Table 54. Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Dipeptidyl Peptidase-4 Inhibitors
Table 62. Key Market Challenges & Risks of Dipeptidyl Peptidase-4 Inhibitors
Table 63. Key Industry Trends of Dipeptidyl Peptidase-4 Inhibitors
Table 64. Dipeptidyl Peptidase-4 Inhibitors Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Dipeptidyl Peptidase-4 Inhibitors Distributors List
Table 67. Dipeptidyl Peptidase-4 Inhibitors Customer List
Table 68. Global Dipeptidyl Peptidase-4 Inhibitors Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Dipeptidyl Peptidase-4 Inhibitors Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Dipeptidyl Peptidase-4 Inhibitors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Dipeptidyl Peptidase-4 Inhibitors Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Dipeptidyl Peptidase-4 Inhibitors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Dipeptidyl Peptidase-4 Inhibitors Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Dipeptidyl Peptidase-4 Inhibitors Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Merck Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 84. Merck Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Boehringer Ingelheim Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 89. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Latest Developments
Table 92. AstraZeneca Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 94. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Takeda Pharmaceutical Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 98. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 99. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Takeda Pharmaceutical Main Business
Table 101. Takeda Pharmaceutical Latest Developments
Table 102. Novartis Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 104. Novartis Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. Jiangsu Hansoh Pharmaceutical Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 108. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 109. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Jiangsu Hansoh Pharmaceutical Main Business
Table 111. Jiangsu Hansoh Pharmaceutical Latest Developments
Table 112. Qilu Pharmaceutical Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 113. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 114. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Qilu Pharmaceutical Main Business
Table 116. Qilu Pharmaceutical Latest Developments
Table 117. Beijing Tide Pharmaceutical Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 118. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 119. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Beijing Tide Pharmaceutical Main Business
Table 121. Beijing Tide Pharmaceutical Latest Developments
Table 122. CTTQ Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 123. CTTQ Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 124. CTTQ Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. CTTQ Main Business
Table 126. CTTQ Latest Developments
Table 127. Jiangsu Deyuan Pharmaceutical Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 129. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Jiangsu Deyuan Pharmaceutical Main Business
Table 131. Jiangsu Deyuan Pharmaceutical Latest Developments
Table 132. Jiujiang Zhongtian Pharmaceutical Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 134. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Jiujiang Zhongtian Pharmaceutical Main Business
Table 136. Jiujiang Zhongtian Pharmaceutical Latest Developments
Table 137. Yabao Pharmaceutical Basic Information, Dipeptidyl Peptidase-4 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 138. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product Portfolios and Specifications
Table 139. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Yabao Pharmaceutical Main Business
Table 141. Yabao Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Dipeptidyl Peptidase-4 Inhibitors
Figure 2. Dipeptidyl Peptidase-4 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dipeptidyl Peptidase-4 Inhibitors Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Sitagliptin
Figure 10. Product Picture of Saxagliptin
Figure 11. Product Picture of Vildagliptin
Figure 12. Product Picture of Linagliptin
Figure 13. Product Picture of Alogliptin
Figure 14. Product Picture of Other
Figure 15. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type in 2022
Figure 16. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Type (2018-2023)
Figure 17. Dipeptidyl Peptidase-4 Inhibitors Consumed in Hospital
Figure 18. Global Dipeptidyl Peptidase-4 Inhibitors Market: Hospital (2018-2023) & (K Units)
Figure 19. Dipeptidyl Peptidase-4 Inhibitors Consumed in Clinic
Figure 20. Global Dipeptidyl Peptidase-4 Inhibitors Market: Clinic (2018-2023) & (K Units)
Figure 21. Dipeptidyl Peptidase-4 Inhibitors Consumed in Other
Figure 22. Global Dipeptidyl Peptidase-4 Inhibitors Market: Other (2018-2023) & (K Units)
Figure 23. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2022)
Figure 24. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Application in 2022
Figure 25. Dipeptidyl Peptidase-4 Inhibitors Sales Market by Company in 2022 (K Units)
Figure 26. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Company in 2022
Figure 27. Dipeptidyl Peptidase-4 Inhibitors Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Company in 2022
Figure 29. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Dipeptidyl Peptidase-4 Inhibitors Sales 2018-2023 (K Units)
Figure 32. Americas Dipeptidyl Peptidase-4 Inhibitors Revenue 2018-2023 ($ Millions)
Figure 33. APAC Dipeptidyl Peptidase-4 Inhibitors Sales 2018-2023 (K Units)
Figure 34. APAC Dipeptidyl Peptidase-4 Inhibitors Revenue 2018-2023 ($ Millions)
Figure 35. Europe Dipeptidyl Peptidase-4 Inhibitors Sales 2018-2023 (K Units)
Figure 36. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue 2018-2023 ($ Millions)
Figure 39. Americas Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country in 2022
Figure 40. Americas Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country in 2022
Figure 41. Americas Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2018-2023)
Figure 42. Americas Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2018-2023)
Figure 43. United States Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Region in 2022
Figure 48. APAC Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Regions in 2022
Figure 49. APAC Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2018-2023)
Figure 50. APAC Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2018-2023)
Figure 51. China Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country in 2022
Figure 59. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country in 2022
Figure 60. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2018-2023)
Figure 61. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2018-2023)
Figure 62. Germany Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2018-2023)
Figure 71. Egypt Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Dipeptidyl Peptidase-4 Inhibitors Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Dipeptidyl Peptidase-4 Inhibitors in 2022
Figure 77. Manufacturing Process Analysis of Dipeptidyl Peptidase-4 Inhibitors
Figure 78. Industry Chain Structure of Dipeptidyl Peptidase-4 Inhibitors
Figure 79. Channels of Distribution
Figure 80. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Forecast by Region (2024-2029)
Figure 81. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share Forecast by Application (2024-2029)